|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support (CORE) Grant
|
5P30CA016672-42
|
$10,405,362
|
$104,054
|
DMITROVSKY, ETHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$70,600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$135,308
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$62,635
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
5P30CA068485-22
|
$5,853,094
|
$58,531
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
$58,154
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$153,890
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA016058-41
|
$5,040,816
|
$50,408
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
$97,910
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
University of Colorado Cancer Center Support Grant
|
2P30CA046934-29
|
$3,880,607
|
$38,806
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Core Support for Cancer Center
|
5P30CA013330-45
|
$3,646,138
|
$36,461
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Stanford Cancer Institute
|
5P30CA124435-10
|
$3,338,488
|
$33,385
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant P30
|
5P30CA093373-15
|
$3,005,659
|
$60,113
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Moffitt Cancer Center Support Grant
|
2P30CA076292-19
|
$2,990,966
|
$29,910
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Cancer Center Support Grant
|
3P30CA072720-19S4
|
$2,945,907
|
$29,459
|
LIBUTTI, STEVEN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-52
|
$2,763,834
|
$27,638
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Program Project in Models of Breast Cancer
|
5P01CA094060-14
|
$2,620,541
|
$131,027
|
NORTON, LARRY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
|
1P01CA210961-01A1
|
$2,339,503
|
$280,740
|
ESSERMAN, LAURA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA062203-20
|
$2,317,496
|
$69,525
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Mayo Clinic Ovarian Cancer SPORE
|
5P50CA136393-08
|
$2,300,000
|
$115,000
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
SPORE in Breast Cancer
|
5P50CA098131-16
|
$2,300,000
|
$575,000
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
|
5P50CA070907-19
|
$2,299,998
|
$115,000
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-18
|
$2,184,000
|
$21,840
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$108,208
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Fred & Pamela Buffett Cancer Center Support Grant
|
5P30CA036727-31
|
$2,107,000
|
$105,350
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
MD Anderson Cancer Center Prostate Cancer SPORE
|
5P50CA140388-07
|
$2,100,013
|
$84,001
|
LOGOTHETIS, CHRISTOPHER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-23
|
$2,093,000
|
$62,790
|
MESA, RUBEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
5P50CA168504-05
|
$2,051,965
|
$61,559
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
1P50CA217685-01
|
$1,732,856
|
$346,571
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant (CORE) Renewal
|
5P30CA023168-37
|
$1,544,675
|
$77,234
|
RATLIFF, TIMOTHY
|
PURDUE UNIVERSITY
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
2R44CA162629-02A1
|
$1,154,726
|
$288,682
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II
|
2R44CA203166-02
|
$1,138,475
|
$1,138,475
|
ZINNEN, SHAWN
|
MBC PHARMA, INC.
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$1,007,541
|
$302,262
|
Gottesman, Michael
|
CCR (NCI)
|
|
Impact of Hearing Loss and Tinnitus in Cancer Survivors
|
1R01CA212064-01A1
|
$904,351
|
$904,351
|
MIASKOWSKI, CHRISTINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-42
|
$789,141
|
$78,914
|
PAGANO, JOSEPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
$7,499
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Pharmacogenomics of Microtubule Targeting Agents
|
5R01CA192156-03
|
$735,702
|
$242,782
|
KROETZ, DEANNA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Exosomal Drug Delivery
|
1R44CA221487-01
|
$719,680
|
$719,680
|
GUPTA, RAMESH
|
3P BIOTECHNOLOGIES, INC.
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$665,821
|
$99,873
|
Brechbiel, Martin
|
CCR (NCI)
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$625,665
|
$31,283
|
Dahut, William
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
$176,320
|
Gottesman, Michael
|
CCR (NCI)
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-02
|
$577,463
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling
|
1U01CA213759-01
|
$515,198
|
$170,015
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
|
5R01CA184968-04
|
$509,161
|
$254,581
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
|
5R01CA208254-02
|
$481,793
|
$144,538
|
SWEENEY, CHRISTOPHER
|
DANA-FARBER CANCER INST
|
|
The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN
|
5R01CA200263-02
|
$479,883
|
$479,883
|
DOUGHERTY, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer
|
1R01CA209818-01A1
|
$470,010
|
$117,503
|
MINKO, TAMARA
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-09
|
$461,999
|
$231,000
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
|
1R01CA219399-01
|
$451,366
|
$225,683
|
LI, SONG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
Total relevant funding to Taxol for this search: $21,807,981
|